Zeltiq Aesthetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 42   

Articles published

ZLTQ 19.26 +0.26 (1.37%)
price chart
ZELTIQ Aesthetics Inc.: ZELTIQ Announces Conference Call and Webcast of ...
PLEASANTON, CA -- (Marketwired) -- 04/15/14 -- ZELTIQ� (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans ...
ZELTIQ Announces Conference Call and Webcast of First Quarter 2014 ...  MarketWatch
Related articles »  
CoolSculpting for thighs
The FDA clears Zeltiq Aesthetics' (ZLTQ +0.6%) entire suite of CoolSculpting applicators to treat thighs. Previously, it was approved to treat only the abdomen and flanks.
Cantor Positive on FDA Approval of ZELTIQ Aesthetics' (ZLTQ) Thigh Area ...  StreetInsider.com (subscription)
Zeltiq Aesthetics Gets FDA Clearance To Treat Thigh  NASDAQ
Related articles »  
Insider Selling: Mark Foley Sells 7123 Shares of ZELTIQ Aesthetics Stock (ZLTQ)
Analysts expect that ZELTIQ Aesthetics will post $-0.36 EPS for the current fiscal year. Zeltiq Aesthetics, Inc operates as a medical device development company.
Small Cap Recent Insider Selling: Arena Pharmaceuticals (NASDAQ:ARNA ...
ZELTIQ Aesthetics Inc (NASDAQ:ZLTQ) CTO Leonard Debenedictis sold 10,071 shares of the stock on the open market in a transaction that occurred on Thursday, April 10th.
Related articles »  
ZELTIQ Aesthetics CTO Unloads $187421 in Stock (ZLTQ)
ZELTIQ Aesthetics presently has a consensus rating of �Buy� and a consensus price target of $23.11. Zeltiq Aesthetics, Inc operates as a medical device development company. It engages in the design, development, and commercialization of non-invasive ...
ZELTIQ Aesthetics CTO Leonard Debenedictis Sells 10071 Shares (ZLTQ)  Zolmax
Worth Watching Stocks � Affymetrix, (NASDAQ:AFFX), ZELTIQ� Aesthetics ...  Techsonian (press release)
Related articles »  
Progenics Pharmaceuticals Inc Initiates Clinical Development And Zeltiq ...
Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) won Food & Drug Administration clearance to use the company's fat-chilling procedure for reducing fat on the thighs, said the company.
Insider Selling: ZELTIQ Aesthetics CFO Sells 5000 Shares of Stock (ZLTQ)
Analysts expect that ZELTIQ Aesthetics will post $-0.36 EPS for the current fiscal year. Zeltiq Aesthetics, Inc operates as a medical device development company.
ZELTIQ Aesthetics VP Sells $45411 in Stock (ZLTQ)  Mideast Time
Related articles »  
Stock's Buzzers - Hatteras Financial Corp. (NYSE:HTS), Zeltiq Aesthetics Inc ...
Las Vegas, NV - March 26, 2014 - (TechSonian) �Hatteras Financial Corp. (NYSE:HTS) released cash dividends on shares of both its common and preferred stock for the first quarter of 2014.
ZELTIQ Aesthetics Receives Consensus Rating of �Buy� from Brokerages ...  Ticker Report
Related articles »  
Notable Movers � Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) Allscripts Healthcare ...
Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) remained among the day bears with 2.21% and traded with volume of 1.03 million shares in the last session, as compared to average volume of 625,670 shares.
Small Cap Most Voaltile Stocks: Ultragenyx Pharmaceutical (NASDAQ:RARE ...
Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) shares advanced 7.07% in last trading session and ended the day on $19.23. ZLTQ return on equity ratio is recorded as -30.00% and its return on assets is -23.00%.